BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26411639)

  • 1. Retracted: Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.
    Pan Q; Luo X; Chegini N
    J Cell Mol Med; 2015 Oct; 19(10):2512. PubMed ID: 26411639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction: Celastrol inhibit the proliferation, invasion and migration of human cervical HeLa cancer cells through down-regulation of MMP-2 and MMP-9.
    J Cell Mol Med; 2024 May; 28(9):e18326. PubMed ID: 38682752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction: Naringenin inhibits migration, invasion, induces apoptosis in human lung cancer cells and arrests tumour progression in vitro.
    J Cell Mol Med; 2024 May; 28(9):e18325. PubMed ID: 38682749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction.
    Acta Obstet Gynecol Scand; 2014 Apr; 93(4):440. PubMed ID: 24450806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566.
    Deacon RMJ; Hurley MJ; Rebolledo CM; Snape M; Altimiras FJ; Farías L; Pino M; Biekofsky R; Glass L; Cogram P
    Genes Brain Behav; 2017 Sep; 16(7):739. PubMed ID: 28211606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Spontaneous rectus sheath haematoma associated with rivaroxaban treatment.
    Tas Tuna A; Palabiyik O; Beyaz SG
    J Clin Pharm Ther; 2015 Aug; 40(4):486-8. PubMed ID: 25381906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction.
    Int J Cancer; 2015 Oct; 137(8):2041. PubMed ID: 26252813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: 'Ergothioneine represses inflammation and dysfunction in human endothelial cells exposed to oxidized low-density lipoprotein' by Lunna Saing, Yu-Chi Wei and Chih-Jen Tseng.
    Clin Exp Pharmacol Physiol; 2016 Jul; 43(7):720. PubMed ID: 25676912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction: 'ASPM predicts poor prognosis and regulates cell proliferation in bladder cancer'. Zhen-Ya Gao, Fang Yu, Huan-Xia Jia, Zhuo Ye, Shi-Jie Yao, Kaohsiung J Med Sci. 2020; 36: 1021-1029 (https://doi.org/10.1002/kjm2.12284).
    Kaohsiung J Med Sci; 2024 Mar; ():. PubMed ID: 38546275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retraction: Sophocleous, M. (2012). On understanding and predicting groundwater response time. Ground Water, 50: 528–540. doi: 10.1111/j.1745-6584.2011.00876.x.
    Ground Water; 2014; 52(2):322. PubMed ID: 24754059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans.
    Bae SH; Park WS; Han S; Park GJ; Lee J; Hong T; Jeon S; Yim DS
    Biopharm Drug Dispos; 2017 Jul; 38(5):363. PubMed ID: 28027398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction statement: Investigating factors associated with nurses' attitudes towards perinatal bereavement care: a study in Shandong and Hong Kong.
    J Clin Nurs; 2015 Sep; 24(17-18):2687. PubMed ID: 26311522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction.
    Int J Cancer; 2016 Nov; 139(9):2146. PubMed ID: 27534920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: FLT3: beyond good and evil.
    Lagunas-Rangel FA; Cortes-Penagos C; Viveros-Sandoval ME
    Hematol Oncol; 2016 Jul; ():. PubMed ID: 27468697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction: 'Genotyping of CYP2C19 polymorphisms and its clinical validation in the ethnic Arab population', by T. Tayeb, Dana H. Bakheet, Khaled Zaza, Salma M. Wakil and Nduna Dzimiri.
    J Pharm Pharmacol; 2016 Mar; 68(3):421. PubMed ID: 27085861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction statement: Dynamics of Cytochrome C Oxidase Activity in Acute Ischemic Stroke' by Selaković, V.M., Jovanović, M.D., Mihajlović, R.R. and Radenović, L.L.J.
    Acta Neurol Scand; 2016 Oct; 134(4):309. PubMed ID: 27592845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction.
    Int J Cancer; 2016 Nov; 139(9):2145. PubMed ID: 27534918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction statement: Advances in the physiological and pathological implications of cholesterol.
    Biol Rev Camb Philos Soc; 2015 Aug; 90(3):996. PubMed ID: 27540895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Impact of Type 2 diabetes prevention programmes based on risk identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis.
    Diabet Med; 2016 Aug; 33(8):1155-63. PubMed ID: 26435275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction.
    Int J Cancer; 2016 Nov; 139(9):2145-6. PubMed ID: 27534917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.